19 results for author:"Wucherpfennig K.W." in Literature citations
Results Customize
› Repeat search in UniProtKB (10)
| Alternative RISC assembly: binding and repression of microRNA-mRNA duplexes by human Ago proteins. Janas M.M., Wang B., Harris A.S., Aguiar M., Shaffer J.M., Subrahmanyam Y.V., Behlke M.A., Wucherpfennig K.W., Gygi S.P., Gagnon E. et al. RNA 18:2041-2055(2012) · Mapped (6) |
| Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Acton S.E., Astarita J.L., Malhotra D., Lukacs-Kornek V., Franz B., Hess P.R., Jakus Z., Kuligowski M., Fletcher A.L., Elpek K.G. et al. Immunity 37:276-289(2012) · Mapped (22) |
| The structural basis for intramembrane assembly of an activating immunoreceptor complex. Call M.E., Wucherpfennig K.W., Chou J.J. Nat. Immunol. 11:1023-1029(2010) · UniProtKB (2) |
| Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Xu C., Gagnon E., Call M.E., Schnell J.R., Schwieters C.D., Carman C.V., Chou J.J., Wucherpfennig K.W. Cell 135:702-713(2008) · Mapped (1) |
| Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Verginis P., McLaughlin K.A., Wucherpfennig K.W., von Boehmer H., Apostolou I. Proc. Natl. Acad. Sci. U.S.A. 105:3479-3484(2008) · Mapped (2) |
| Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Lu L., Ikizawa K., Hu D., Werneck M.B., Wucherpfennig K.W., Cantor H. Immunity 26:593-604(2007) · Mapped (78) |
| Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). Garibyan L., Lobito A.A., Siegel R.M., Call M.E., Wucherpfennig K.W., Geha R.S. J. Clin. Invest. 117:1550-1557(2007) · Mapped (9) |
| Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Backstrom B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B. et al. Nat. Med. 13:423-431(2007) · Mapped (2) |
| Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. Moza B., Varma A.K., Buonpane R.A., Zhu P., Herfst C.A., Nicholson M.J., Wilbuer A.K., Seth N.P., Wucherpfennig K.W., McCormick J.K. et al. |
| The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor. Call M.E., Schnell J.R., Xu C., Lutz R.A., Chou J.J., Wucherpfennig K.W. |
| A membrane-proximal tetracysteine motif contributes to assembly of CD3deltaepsilon and CD3gammaepsilon dimers with the T cell receptor. Xu C., Call M.E., Wucherpfennig K.W. J. Biol. Chem. 281:36977-36984(2006) · Mapped (9) |
| The assembly of diverse immune receptors is focused on a polar membrane-embedded interaction site. Feng J., Call M.E., Wucherpfennig K.W. PLoS Biol. 4:e142-e142(2006) · Mapped (18) |
| Small molecules that enhance the catalytic efficiency of HLA-DM. Nicholson M.J., Moradi B., Seth N.P., Xing X., Cuny G.D., Stein R.L., Wucherpfennig K.W. J. Immunol. 176:4208-4220(2006) · UniProtKB (2) |
| Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Hahn M., Nicholson M.J., Pyrdol J., Wucherpfennig K.W. |
| Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes. Havari E., Lennon-Dumenil A.M., Klein L., Neely D., Taylor J.A., McInerney M.F., Wucherpfennig K.W., Lipes M.A. J. Immunol. 173:787-796(2004) · Mapped (21) |
| A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. Taylor J.A., Havari E., McInerney M.F., Bronson R., Wucherpfennig K.W., Lipes M.A. J. Immunol. 172:2651-2658(2004) · Mapped (24) |
| Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Lee K.H., Wucherpfennig K.W., Wiley D.C. Nat. Immunol. 2:501-507(2001) · UniProtKB (2) |
| A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Madsen L.S., Andersson E.C., Jansson L., krogsgaard M., Andersen C.B., Engberg J., Strominger J.L., Svejgaard A., Hjorth J.P., Holmdahl R. et al. Nat. Genet. 23:343-347(1999) · Mapped (4) |
| Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. Smith K.J., Pyrdol J., Gauthier L., Wiley D.C., Wucherpfennig K.W. J. Exp. Med. 188:1511-1520(1998) · UniProtKB (1) · Mapped (2) |